NTL HEALTHCARE Showcases AI Cervical Screening at WHX Johannesburg 2026 and Expands in Africa

NTL HEALTHCARE Accelerates Expansion in Africa with CerviCARE AI

In an impressive showcase at the WHX Johannesburg 2026 event, NTL HEALTHCARE introduced its advanced cervical cancer screening system, CerviCARE AI, which leverages artificial intelligence to transform healthcare access across the African continent. The event, held from October 6 to 8, attracted over 200 representatives from various sectors, including healthcare distributors, medical institutions, and policymakers, all converging to explore the potential of this innovative technology.

CerviCARE AI is designed to analyze images of the cervix and identify potential lesions, offering results in less than five seconds without requiring an internet connection. This rapid and accurate screening method has shown a sensitivity of 98% and a specificity of 95.5% in detecting high-risk lesions, as evidenced by multiple studies, including recent findings from StandardBank and an article in Scientific Reports. The AI-driven system provides users with quality image feedback, ensuring consistent and high-quality results, regardless of their skill level.

Addressing Healthcare Gaps in Africa

The introduction of CerviCARE AI comes at a critical time as Africa grapples with high cervical cancer rates. According to the World Health Organization, cervical cancer is the leading cause of cancer death among women in 26 sub-Saharan African countries. These alarming statistics highlight the urgent need for accessible and effective screening solutions in regions struggling with limited healthcare resources. NTL HEALTHCARE's initiative aims to tackle this challenge directly by fostering local partnerships and facilitating the implementation of impactful health technologies.

At the WHX event, NTL HEALTHCARE not only promoted its product but also engaged in meaningful discussions regarding local implementation strategies. The company met with key stakeholders, including South African politicians and academic representatives, to explore pathways for collaboration that could pave the way for effective local market adoption.

Leveraging successful pilot projects previously conducted in Zambia, Uganda, and Tanzania, NTL HEALTHCARE intends to position South Africa as a strategic hub for expansion into neighboring countries and other African markets. The company also announced its engagement in Zimbabwe, further solidifying its regional presence.

Strategic Partnerships for Sustainable Growth

To maximize its impact, NTL HEALTHCARE plans to forge partnerships with international medical foundations and participate in the Korean Knowledge Sharing Program (KSP), a government initiative designed to promote knowledge exchange for economic development. By collaborating with local partners on regulatory approvals, training, and operational planning, the company aims to develop sustainable health solution models tailored to the unique needs of African countries.

The implementation of innovative screening technologies requires not only validation but also strong political support to gain traction within healthcare systems. Tae-hee Kim, CEO of NTL HEALTHCARE, emphasized the importance of community involvement and practical validation during the company's discussions with South African stakeholders, underscoring the lessons learned from their pilot projects.

Founded in 1996, NTL HEALTHCARE has established a strong international footprint, providing CerviCARE AI to more than 20 countries worldwide. With its sights set on broadening distribution and strengthening partnerships throughout Africa, the company is determined to play a vital role in enhancing women's health and reducing the burden of cervical cancer across the continent.

Conclusion

As NTL HEALTHCARE embarks on this ambitious expansion journey, the introduction of CerviCARE AI at WHX Johannesburg 2026 marks a significant step forward in the quest for improved healthcare outcomes in Africa. With its commitment to collaboration and innovation, the company is poised to make a meaningful difference in the fight against cervical cancer and to set a benchmark for how technology can bridge healthcare gaps in resource-poor regions.